Full-Body Scans Can Find Trouble That May Never Have Mattered
Lori Baute’s experience captures the appeal of consumer-facing screening in one vivid sequence: worry, test, panic, and then relief after a second look. At 59, with a family history of cancer and heavy caregiving responsibilities, she chose a full-body MRI scan offered near her home in Ocala, Florida. The scan found lesions on her pancreas. A follow-up targeted MRI later showed benign cysts.
The episode ended without a cancer diagnosis, but it still carried a clinical price. The first scan created a threat that did not exist in the form she feared, and it set off a chain of monitoring that will continue with annual scans. For patients, that kind of result can feel like control. For medicine, it is a reminder that screening is not the same as care, and detection is not the same as benefit.
Why More Testing Does Not Always Mean Better Care
Direct-to-consumer body scans and at-home blood tests are increasingly marketed as tools for early detection, especially for people anxious about cancer or other silent disease. Yet major medical groups, including the American Cancer Society and the American College of Radiology, do not recommend full-body scans for people without a very high risk of specific cancers. The problem is not just whether a test can find something. The real question is whether it finds the right thing, at the right time, in a way that improves outcomes rather than intensifying fear and follow-up procedures.
Every test carries a cost. Sometimes the cost is obvious: cash out of pocket, time off work, travel, and the wait for results. Some tests are physically minor, limited to blood draws or sample collection. Others carry direct medical risk. CT scans expose patients to radiation, and repeated exposure can raise cancer risk over time. Biopsies and endoscopies can cause pain, infection, tearing, anesthesia reactions, and in some cases severe complications.
A test can also injure without touching the body at all. Uncertain results can leave patients trapped in a loop of repeated imaging, repeat consultations, and fear that lasts far longer than the appointment itself.
The Diagnostic Cascade Can Become the Real Story
In clinical practice, one ambiguous result often begets another. That progression is known as a diagnostic cascade. It begins with a scan or lab test that suggests a possible abnormality, then moves to more targeted imaging, specialist visits, procedures, and sometimes surgery. Each step is justified by the one before it, even when the first test never had a clear reason to be ordered.
Rita Redberg, a University of California-San Francisco professor and cardiologist who argues for less medical testing, said she sees patients regularly who are distressed by results they never needed to obtain in the first place. A cyst, for example, can become a long-term source of surveillance. Once it appears on a report, the body part is no longer simply an organ; it becomes a timeline of uncertainty, repeated scans, and the possibility of escalation if the image changes in any way.
A separate example cited in JAMA Internal Medicine shows how far that escalation can go. A 52-year-old woman with chest pain and low apparent risk for heart disease underwent a heart scan to reassure her. The scan led to another test, during which her artery was torn. She required emergency bypass surgery, suffered complications, and ultimately needed a heart transplant. The chain began with reassurance and ended with profound harm.
One unnecessary test can become a medical emergency.
Why Symptoms and Risk Level Should Drive the Decision
The clinical logic behind testing is straightforward: symptoms, exam findings, and risk profile should guide what happens next. When those inputs are weak, the test itself can dominate decision-making. A low-risk patient with nonspecific pain may end up in a pathway that reveals incidental findings unrelated to the original complaint. In a high-risk patient, by contrast, the same test may reveal disease early enough to change management. The difference lies in pretest probability, not in the glamour of the machine.
That is why Redberg advises patients to ask three plain questions before agreeing to a test: What will I learn? How will this change my care? Could I improve my health without doing this? Those questions force the conversation back to clinical utility. If the answer is lifestyle counseling, blood pressure control, smoking cessation, or weight management, the best next step may not require imaging at all.
For many cardiology patients, in particular, test results lead back to the same evidence-based advice: eat well, exercise, and do not smoke. Those recommendations matter, but they do not require a scan to exist. Sometimes the best intervention is the one that was available before the machine was turned on.
Insurance Coverage Often Signals Evidence, Not Just Access
Coverage status can offer a useful clue about whether a test has been vetted for meaningful benefit. Private insurers, Medicaid, and Medicare must cover preventive services with an A or B rating from the U.S. Preventive Services Task Force. Those ratings are based on evidence that a service helps patients enough to justify its use. Many consumer-marketed tests fall outside that framework and are not covered by insurance.
That distinction matters at the bedside and at the kitchen table. If a test is paid for out of pocket, the patient is not only assuming financial risk but also buying into whatever uncertainty or follow-up the result may generate. A scan that finds something benign can still rearrange a person’s life, as Baute’s pancreatic cyst did. A negative result can offer reassurance, but it can also lull a person into false confidence if the test was never designed to answer the question they were asking.
The safest path is not automatic testing and not automatic refusal. It is a conversation grounded in evidence, actual risk, and the consequences of what happens next if the image, lab value, or biopsy result is unclear. The bigger question is not whether a test can be done. It is whether it should be done in this person, at this moment, for this reason.